Subependymal giant cell astrocytoma history and symptoms: Difference between revisions
| Line 14: | Line 14: | ||
*Vomiting | *Vomiting | ||
*Seizures | *Seizures | ||
*Memory loss | |||
*Personality change | |||
==Symptoms== | ==Symptoms== | ||
Revision as of 02:16, 27 October 2019
|
Subependymal giant cell astrocytoma Microchapters |
|
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subependymal giant cell astrocytoma history and symptoms On the Web |
|
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma history and symptoms |
|
FDA on Subependymal giant cell astrocytoma history and symptoms |
|
CDC on Subependymal giant cell astrocytoma history and symptoms |
|
Subependymal giant cell astrocytoma history and symptoms in the news |
|
Blogs on Subependymal giant cell astrocytoma history and symptoms |
|
Risk calculators and risk factors for Subependymal giant cell astrocytoma history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
When evaluating a patient for subependymal giant cell astrocytoma, you should take a detailed history of the presenting symptom (onset, duration, and progression), other associated symptoms, and a thorough family and past medical history review. Other specific areas of focus when obtaining the history include review of common associated conditions such as tuberous sclerosis.[1] Symptoms of subependymal giant cell astrocytoma include headache, seizures, vision loss, changes in speech, weakness in limbs, and sensory loss.[2][3][4]
History
Patients with subependymal giant cell astrocytoma may have a positive history of:
- Genetic disorders such as:
- Tuberous sclerosis
- Headache
- Nausea
- Vomiting
- Seizures
- Memory loss
- Personality change
Symptoms
Majority of the symptoms experienced by patients with subependymal giant cell astrocytoma are due to obstruction of the foramen of monroe. Symptoms of subependymal giant cell astrocytoma include:[2][3][4][5][6]
- Headaches
- Nausea
- Vomiting
- Diplopia
- Vision loss
- New onset seizures
- Worsening of seizure control
- Changes in speech
- Memory loss
- Personality changes
- Weakness in limbs
- Sensory loss
- Balance difficulties
- Fatigue
- Decreased appetite
- Cognitive decline
- Sleep disorder
References
- ↑ Roth, Jonathan; Roach, E. Steve; Bartels, Ute; Jóźwiak, Sergiusz; Koenig, Mary Kay; Weiner, Howard L.; Franz, David N.; Wang, Henry Z. (2013). "Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012". Pediatric Neurology. 49 (6): 439–444. doi:10.1016/j.pediatrneurol.2013.08.017. ISSN 0887-8994.
- ↑ 2.0 2.1 Jóźwiak S, Nabbout R, Curatolo P, participants of the TSC Consensus Meeting for SEGA and Epilepsy Management (2013). "Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations". Eur J Paediatr Neurol. 17 (4): 348–52. doi:10.1016/j.ejpn.2012.12.008. PMID 23391693.
- ↑ 3.0 3.1 Ouyang, Taohui; Zhang, Na; Benjamin, Thomas; Wang, Long; Jiao, Jiantong; Zhao, Yiqing; Chen, Jian (2014). "Subependymal giant cell astrocytoma: current concepts, management, and future directions". Child's Nervous System. 30 (4): 561–570. doi:10.1007/s00381-014-2383-x. ISSN 0256-7040.
- ↑ 4.0 4.1 Symptoms of subependymal giant cell astrocytoma. University of Pittsburgh Medical Center 2015. http://www.upmc.com/services/neurosurgery/brain/conditions/brain-tumors/pages/subependymal-giant-cell-astrocytoma.aspx. Accessed on November 5, 2015
- ↑ Koenig MK, Butler IJ, Northrup H (2008). "Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex". J Child Neurol. 23 (10): 1238–9. doi:10.1177/0883073808321764. PMC 3072698. PMID 18952591.
- ↑ Goh S, Butler W, Thiele EA (2004). "Subependymal giant cell tumors in tuberous sclerosis complex". Neurology. 63 (8): 1457–61. doi:10.1212/01.wnl.0000142039.14522.1a. PMID 15505165.